KUALA LUMPUR, MALAYSIA – 27th July, 2011 – Swiss-based International Biotechnology Leader, FETAL CELL TECHNOLOGIES INTERNATIONAL INC. (FCTI), through its Sabah-based Asia-Pacific Regional Hub office, led by its respective CEO Michelle Wong, has been awarded a total of three (3) Entrepreneur Excellence Awards by the Entrepreneur Development Association and Asia Pacific Excellence Alliance at the 10th Asia Pacific International Entrepreneur Excellence Awards 2011 Ceremony. Fetal Cell Technologies International Inc. is the world's leading provider of the pioneering modern regenerative therapy – Fetal Precursor Stem cells. These Excellence Awards include the Excellence Brand Award, Excellence Product Award and Excellence Leadership Award for FCTI Asia Pacific Regional Hub. The prestigious honors were awarded at the 10th Asia-Pacific International Entrepreneur Excellence awards Ceremony held on the 27th July at the 5-star Sunway Resort Hotel and Spa in Kuala Lumpur, Malaysia. With close to 1000 nominees from counterparts within the whole Asia-Pacific region, the Entrepreneur Development Association and the Asia-Pacific Excellence Entrepreneur Alliance have conducted careful preliminary evaluation of all the nominated companies based on their eligibility and dedication towards establishing and maintaining good corporate records. Eligible nominees were then judged based on 5 core criteria – Business and Company, Management Philosophies, Operations and Technologies, Financial Performance and Corporate Social Responsibility. |
|
 |
In the final stages, Michelle Wong, the CEO of Fetal Cell Technologies International Inc. represented the Asia-Pacific Regional Hub of the company at the final stringent judging process, involving esteemed professional members of the International Entrepreneur Council. The long track record, clean history, outstanding inventions, prestigious quality assurance, effective marketing strategies and potential for further international expansion have been highlighted by the International Council members as the most meritorious hallmarks of FCTI. “Entrepreneurs provide the backbone to a nation’s economic sustainability. As they create new products, services, markets and channels, they too create numerous employment opportunities that reduce the gap between the rich and poor. There is no doubt that in the current period of global economic uncertainty, we need entrepreneurs even more than usual,” said Prime Minister Malaysia YAB Dato’ Seri Haji Mohd Najib Bin Razak, who was represented by the Minister in the Prime Minister’s Department, Y.B. Senator Tan Sri Dr. Koh Tsu Koon during the Excellence Award Ceremony 2011. Organized in response to the Government's support for industrial development and advancement, the 2011 Asia Pacific Entrepreneur Excellence Awards serve as a testament to the potential and strengths of the company, and an important recognition of FCTI's Precursor Stem Cell Therapy in this region. Michelle Wong added, “We will further strive to bring in more Swiss technologies and foreign experts in the field of Regenerative Medicine and Stem Cell Therapy to be based, our Asia Pacific Regional Hub. |
To ensure a progressive development of our regenerative medicine for people around the world is of paramount importance to me, as I fervently believe in the Swiss Cell Therapy methodology of adding more life to years than years to life.” The Swiss-based Multinational Company, FCTI, would be venturing to construct a new Asia Pacific Regional Hub. This will include a modern-styled multi-storey corporate building, in addition to their already built up bungalow lots, occupying more than 50,000 sq. feet of working space embracing an exquisite working environment. It also includes a bonded warehouse, high-end biotechnology research labs, a pharmaceutical plant for biotech products currently manufactured in Switzerland, Germany and Europe, a modern stem cell Research and Development plant and exclusive meeting-cum-training areas for physicians in the anti-ageing field and international guests. Moreover, the building will accommodate the existing workforce, comprised of more than 10 different nationalities including Russian, Spanish, French, German, British, Latin American, Japanese, Chinese, American and Swiss. In addition, there will be a team of full-time Medical Anti-Aging Doctors and Scientists from Switzerland, USA, Germany and Russia to conduct research and development, clinical studies and logistics studies for the Asia Pacific. This bold venture heralds a promising future for FCTI in the Asia-Pacific area, as its KKIP-based Asia Pacific Hub will be the largest precursor stem-cell therapy establishment in the region. With the importation of modern Swiss technology, several of Europe’s leading biotechnologists, stem cell experts and medical consultants as well as state-of-the-art facilities by the two Sabah-based companies, Sabah is set to evolve as the center of biotechnological developments in the Asian region. |
In March 2011, FCTI was a specially invited speaker at the Brunei-Indonesia-Malaysia-Philippines East ASEAN Growth Area (BIMP-EAGA) Expo attended by former Philippines President Fidel V. Ramos. Motivated by the vision to strengthen ties and to encourage innovations and technological developments, BIMP-EAGA Expo culminated with a resounding success and served as a pivotal recognition of FCTI’s potentials to be leaders in the region. FCTI is the world’s leading provider of Fetal Precursor Stem Cells. This individualized regenerative therapy has treated with encouraging results a significant number of patients diagnosed with neurological diseases such as Parkinson’s Disease and other chronic diseases such as Diabetic Mellitus and Multiple Sclerosis, as well as genetic disorders commonly diagnosed in children such as Down Syndrome, Autism and Cerebral Palsy. Since 2005, FCTI has conducted close to a thousand precursor stem cell implantations in Asia alone, where patients hailed from multiple countries across Asia-Pacific. To date, FCTI has successfully treated approximately 90 Down Syndrome patients, 30 Autism patients and 30 Cerebral Palsy patients. FCTI has conducted more than 60 Seminars and Educational Training Programmes for physicians worldwide since 2006. For more general product and corporate information, please visit www.fetal-cells.com, www.eco-ultrafiltrates.com and |